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Summary
 
Macrophage tropic HIV-1 is predominant during the initial viremia after person to person
transmission of HIV-1 (Zhu, T., H. Mo, N. Wang, D.S. Nam, Y. Cao, R.A. Koup, and D.D.
Ho. 1993. 
 
Science.
 
 261:1179–1181.), and this selection may occur during virus entry and car-
riage to the lymphoid tissue. Human skin explants were used to model HIV-1 selection that
may occur at the skin or mucosal surface. Macrophage tropic, but not T cell line tropic strains
of HIV-1 applied to the abraded epidermis were recovered from the cells emigrating from the
skin explants. Dermis and epidermis were separated by dispase digestion after virus exposure to
determine the site of viral selection within the skin. Uptake and transmission to T cells of all
HIV-1 isolates was found with the dermal emigrant cells, but only macrophage tropic virus was
transferred by emigrants from the epidermis exposed to HIV-1, indicating selection only
within the epidermis. CD3
 
1
 
, CD4
 
1
 
 T cells were found in both the dermal and epidermal em-
igrant cells. After cell sorting to exclude contaminating T cells, macrophage tropic HIV-1 was
found in both the dermal emigrant dendritic cells and in dendritic cells sorted from the epider-
mal emigrants. These observations suggest that selective infection of the immature epidermal
dendritic cells represents the cellular mechanism that limits the initial viremia to HIV-1 that
can use the CCR5 coreceptor.
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A
 
t least three members of the beta chemokine receptor
family are used by different HIV-1 isolates as corecep-
tors for HIV-1 viral entry (1–4). This discovery has clari-
fied some of the confusion of the earlier classifications of
cellular tropism of HIV-1, based on their ability to infect
macrophages or the human T lymphotropic virus type 1
transformed T cell line MT-2 (5). The differences in host
cell preference can largely be attributed to the differing
ability of HIV-1 isolates to use alternative coreceptors (6–8).
CXCR4 is used by HIV-1 strains that preferentially enter
T cell lines resulting in the syncytia-inducing (SI)
 
1
 
 biologi-
cal phenotype (4). CCR5 and, less commonly, CCR3 or
CCR2b are used by HIV-1 that enters macrophages result-
ing in the macrophage tropic biological phenotype (9).
Activated primary T cells and nontransformed T cell lines
express both CXCR4 and CCR5 and can be infected by
all isolates irrespective of the virus phenotype. Confusion in
classification has arisen because use of CCR5 or CXCR4 is
not mutually exclusive and there is overlap between SI and
macrophage tropism. The envelope of such dual tropic virus
isolates that are SI and macrophage tropic can bind to both
CCR5 and CXCR4 and infect T cell lines and macrophages
(7, 9).
Preferential infection by macrophage tropic isolates that
use the CCR5 coreceptor occurs during person to person
transmission of HIV-1 (10–11). Later in disease, quasispe-
cies of HIV-1 emerge that use CXCR4 (12) and have the
ability to infect T cell lines reflected in the SI phenotype
(5, 12, 13). We have shown that tonsil and thymic den-
dritic cells (DCs) can be infected by HIV-1 and that viral
entry is preferential by macrophage tropic HIV-1 (14), sug-
gesting non-CXCR4–dependent entry. Langerhans cells
and DCs are the first cells exposed to infectious organisms
or antigens and migrate with processed antigen. These cells
migrate to draining lymph nodes where cognate T cell in-
teractions initiate immune responses (15). Selective entry of
HIV-1 into DCs and carriage of virus with selected pheno-
type to lymph nodes could therefore explain the restriction
 
1
 
Abbreviations used in this paper:
 
 DC, dendritic cell; NSI, non-SI; SEB, staph-
ylococcus enterotoxin B; SI, syncytia-inducing; TCID
 
50
 
, tissue culture
infections dose 50%.
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of virus phenotype during the initial viremia before sero-
conversion (10).
To study the cellular mechanisms involved in the earliest
events in transmission, we have studied HIV-1 infection of
skin explants. During in vitro culture of murine skin or ear
halves (16) and human (17–19) split thickness skin, DCs
migrate rapidly from the skin explants. We used this cul-
ture system as a model for the uptake of HIV-1 by DCs
that are migrating from body surfaces in vivo, especially
such surfaces as the vagina, cervix, and anal canal that are
histologically so similar to skin, including their content of
DCs. Isolates of HIV-1 that are macrophage tropic/non-SI
(NSI; HIV-1
 
Ba-L
 
, HIV-1
 
676
 
) or T cell line tropic/SI (HIV-
1
 
228
 
, HIV-1
 
NL4.3
 
) were added to these explants in two dif-
ferent ways: directly to the abraded surface of the epidermis
to restrict the exposure to the epidermis, or to the culture
medium allowing both dermal and epidermal exposure.
We also studied skin that had been separated after virus ex-
posure into epidermal and dermal components to deter-
mine which components of skin might be exerting selec-
tion pressure on viral phenotype.
 
Materials and Methods
 
Virus Culture and Infection.
 
Laboratory strains HIV-1
 
Ba-L 
 
(mac-
rophage tropic, NSI in MT-2 cells) and HIV-1
 
NL4.3
 
 (SI in MT-2
cells) and low passage patient isolates HIV-1
 
228
 
 (SI) and HIV-1
 
676
 
(macrophage tropic, NSI) were grown in PBMCs stimulated by
staphylococcus enterotoxin B (SEB; 40 ng/ml; Sigma Chemical
Co., St. Louis, MO). Virus stocks were filtered (0.2-
 
m
 
m filter;
Schleicher and Schuell, Keene, NH) and stored at 
 
2
 
70
 
8
 
C before
use. HIV-1 was treated with RNase-free DNase I (50 U/ml;
Boehringer Mannheim GmbH, Mannheim, Germany) for 15 min
at room temperature. Tropism of the isolates was confirmed by
infection of MT-2 and monocyte-derived macrophages. Infec-
tions with HIV-1 were performed overnight (16–18 h) using
10,000 TCID
 
50
 
 (tissue culture infectious dose 50%) as determined
by infection of activated PBMCs.
 
Virus Infection of Skin Explants.
 
Split thickness skin was pre-
pared from the skin from healthy donors undergoing corrective
surgery of breast or abdomen. The skin was stored at 4
 
8
 
C and
used within 6 h of collection. Skin was incubated in RPMI 1640
with gentamicin (250 
 
m
 
g/ml) for 1 h before abrading the epider-
mal surface with a sterile wire brush or scalpel to disrupt or re-
move the corneal layer. Skin explants were prepared by cutting
the abraded skin into pieces 
 
z
 
2 cm 
 
3 
 
2 cm. Virus was added to
the epidermal surface of the skin after applying sterile petroleum
jelly to the edges of the skin to produce a hydrophobic barrier
confining the inoculum to the epidermis. After overnight virus
exposure, the virus was aspirated from the skin surface and the
skin within the reservoir was washed by repeated addition and as-
piration of PBS (0.5–1 ml, 3–5 min between washes). In other ex-
periments, virus was added directly to 5 ml of culture medium
(RPMI 1640 supplemented with 10% fetal bovine serum (Com-
monwealth Serum Laboratories, Melbourne, Victoria, Australia),
glutamine (2 mM), gentamicin (25 
 
m
 
g/ml), and Hepes (10 mM)).
Infections were performed using 10,000 TCID
 
50
 
 HIV-1, except
as indicated. Virus was removed the next day (16–18 h after inoc-
ulation) by washing the skin three times with PBS without Mg
 
2
 
1
 
or Ca
 
2
 
1
 
. The skin was either returned directly to culture using
fresh medium or treated with dispase before culture.
 
Preparation of Epidermal Sheets.
 
The protocol used for dispase
treatment was modified from the method described by Lenz et al.
(17). Skin explants were washed three times with PBS to remove
residual virus. The skin was incubated with dispase II (5–10 mg/ml;
Boehringer Mannheim GmbH) in RPMI 1640 at 4
 
8
 
C with the
dermal side facing up. After 4–6 h, the skin was washed three
times with PBS to remove dispase, and using fine forceps, the
epidermis was separated from the dermis and both layers washed
in PBS. Epidermal and dermal sheets were floated on 5 ml of cul-
ture medium in 6-well plates for 3–4 d to allow migration of cells
from the separated sheets. Cells were harvested from the medium
after collagenase treatment (1 mg/ml collagenase type 2, for 2 h at
37
 
8
 
C; Worthington, Lakewood, NJ) and washed before adding
to T cells in coculture.
 
Coculture of Emigrant Cells and DCs with T Cells.
 
After 3–4 d,
the skin explants (total area: 3–4 cm
 
2
 
) were removed from each
well and collagenase was added to the medium (1 mg/ml cultured
for 2 h at 37
 
8
 
C). The emigrant cells from each skin explant were
pelleted, resuspended in fresh medium, and divided between
wells containing 10
 
6
 
 resting allogeneic PBMCs or activated PB-
MCs (activated for 3 d with 40 ng/ml SEB or 10 
 
m
 
g/ml PHA) in
24-well microtiter plates. The small area of skin exposed to virus
and the low numbers of cells emigrating from each explant made
enumeration of DC numbers difficult. In most experiments, the
number of DCs migrating from each individual skin explant was
not directly determined and no correction was made for variation
in the number of emigrant cells. Comparisons between different
virus isolates was made using skin from the same donor and were
standardized by area of skin explants, the skin area exposed to
HIV-1, and the TCID
 
50
 
 of the virus inocula.
 
Quantitation of Dendritic Cell Migration from Skin Explants.
 
Half of
the skin explants were abraded and half left intact. Skin explants
were exposed to different HIV-1 isolates by adding virus to the
culture medium. After overnight exposure, the skin was washed, dis-
pase treated, and epidermal and dermal sheets prepared. The emi-
grant cells were counted and emigrants labeled with direct anti-
bodies against HLA-DR (HLA-DR PerCP or HLA-DR-FITC;
Becton Dickinson, San Jose, CA), CD4 (leu3a FITC; Becton
Dickinson), and CD8 (leu2a PE; Becton Dickinson) or CD3
(CD3-PE, Becton Dickinson). Cells were fixed and analyzed on a
FACSort
 
Ò
 
 (Becton Dickinson). The area of epidermal sheets was
determined after harvesting the emigrants using a 2-mm grid
overlay.
 
DC Purification from Skin.
 
Emigrant cells were treated with 1
mg/ml collagenase for 2 h at 37
 
8
 
C and spun over a 1.040/1.070
g/ml step gradient of isoosmotic metrizamide (Nycomed, Oslo,
Norway) to remove nonviable cells and most keratinocytes. Cells
at the 1.040/1.070 interface were stained with FITC-conjugated
anti–HLA-DR (Becton Dickinson) and PE-conjugated anti-CD3
(Becton Dickinson), and sorted using a closed cell sorter (FACS
 
Ò
 
Calibur; Becton Dickinson). The DCs were selected by size, high
DR expression, and absence of CD3 expression.
 
Reverse Transcriptase Assay.
 
Supernatants were collected from
cultures every second day and stored at 
 
2
 
20
 
8
 
C until batch pro-
cessed. The supernatants were assayed for reverse transcriptase ac-
tivity as previously reported (20). Filters were counted using a
micro–beta counter with cross-talk correction (Wallac, Turku,
Finland) after applying Meltilex scintillant (Wallac).
 
Semiquantitative PCR.
 
PCR was performed using 
 
gag
 
-specific
primers (SK38 and SK39) and HLA-DQ primers as controls for
cell number and amplification efficiency by including in a multi-
plex amplification (primers: GH26 and GH27) as previously de-
scribed (20). 
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Results
 
Different HIV-1 isolates of both NSI and SI phenotypes
were carefully applied to the surface of abraded skin ex-
plants using petroleum jelly as a barrier to confine the virus
to the epidermis. After 16–18 h, the virus was removed and
the skin was recultured for 3 d. The DC-enriched emigrat-
ing cells were harvested and cocultured with resting or ac-
tivated allogeneic T cells. Virus production was measured
in cocultures by reverse transcriptase activity in the super-
natant or by semiquantitative PCR for HIV-1 
 
gag
 
 sequences
in the cocultured cells. In this system, some disruption of
the corneal layer of the epidermis was necessary for infec-
tion, as no virus was recovered from the migrating cells
when virus was applied to the surface of nonabraded skin
(data not shown). A high number of infectious particles
needed to be applied to the epidermal surface to recover
virus from the emigrant cells during cocultures (Fig. 1 
 
A
 
).
The transfer of infectious virus across the abraded epidermis
was inefficient, as no virus transfer was demonstrated after
the virus dose applied to the skin surface was reduced from
10,000 to 1,000 TCID
 
50
 
. The higher concentration of vi-
rus 10,000 TCID
 
50
 
 was routinely used for infections.
Quantitatively, the recovery of DCs from the skin ex-
plants was similar to that obtained by others (17). There
was a consistent reduction in cells migrating from the epi-
dermal sheets prepared from abraded skin, but there was no
significant difference in the DC numbers in the emigrants
from dermis or abraded but otherwise untreated split skin
(Fig. 1 
 
B
 
). By flow cytometric analysis, a higher ratio of
DCs to CD4 T cells was found in epidermal emigrants, but
abrasion of the epidermal surface had no detectable effect
on the phenotype of the emigrant cells. Similarly virus ex-
posure did not affect the recovery of DCs migrating from
skin. In three experiments where total emigrant cell recov-
ery, emigrant phenotype, and skin area were determined,
the combined results for mean DC recovery from epidermal
sheets (
 
6
 
SE) were 10,503 (3,294), 14,375 (7,825), 12,555
(8,493) cells/cm
 
2
 
 for explants not exposed to HIV-1, ex-
posed to T cell tropic (NL4.3), or exposed to macrophage
tropic virus (ADA), respectively. The results for abraded skin
explants exposed to the same viruses were 5,776 (3,508),
5,719 (2,197), and 5,260 (1,792).
Comparison of the virus recovery after application of
different virus isolates to the epidermal surface showed se-
lection of macrophage tropic virus during transmission
across the skin explants (Fig. 2). Reverse transcriptase activ-
ity was present in the supernatants and provirus was de-
tected in the cells of the cocultures containing cells migrat-
ing from skin exposed to macrophage tropic virus (Ba-L
and 676; Fig. 2). The cells migrating from skin exposed to
T cell line tropic isolates did not transmit virus (228; Fig. 2).
Next, we examined selection of different strains of HIV-1
by adding virus to the epidermal surface or directly to the
medium in which the abraded skin explants were cultured.
Addition of the virus to the medium allowed HIV-1 expo-
sure of the cells mobilized within the dermis and is compa-
rable to previous studies that have harvested the emigrant
cells and used these cells as target populations (21–24). Our
results were similar to previous studies using isolated emi-
grant cells exposed to HIV-1 in that there was transmission
of all virus strains both macrophage and T cell tropic, from
the HIV-1–exposed dermal emigrants to T cells. There was
a clear difference in the pattern of virus transfer from emi-
Figure 1. Virus dose for infection and phenotype of emigrant cells
from skin explants. (A) HIV-1Ba-L was added to the abraded surface of
skin (epidermis) or to the culture medium (medium) at high (10,000
TCID50, closed symbols) or at low (1,000 TCID50, open symbols) concentra-
tions. After overnight exposure, the explants were washed and returned
to culture for 3 d. The emigrants were divided equally into triplicate co-
cultures with allogeneic T cells (see Materials and Methods). Reverse tran-
scriptase activity was measured at 0, 7, and 9 d of culture. Transmission to
T cells occurred after addition of 10,000 TCID50, but not 1,000 TCID50,
of HIV-1 to the epidermal surface. Transmission occurred at both virus
doses when exposure was via the culture medium. (B) Recovery and phe-
notype of cells from skin explants and dispase-treated skin. Skin explants
with and without epidermal abrasion were cultured and the emigrant cells
from skin explants and from the separated epidermal and dermal sheets
enumerated and phenotype determined by flow cytometry. The areas of
the skin explants and epidermal sheets were measured after culture using a
2-mm grid and the data plotted for cell recovery from triplicate cultures
of 8–13 cm2 of skin. Results are representative of three similar experiments. 
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grant cells to T cells after epidermal virus exposure, com-
pared with simultaneous epidermal and dermal exposure
(Fig. 3 
 
A
 
). The cells migrating from dermis exposed to vi-
rus, transferred all of the virus isolates we tested whether
they were T cell line (228; Fig. 3 
 
A
 
) or macrophage tropic
(Ba-L; Fig. 3 
 
A
 
). For similar viral inocula added to the epi-
dermal surface of the skin (Fig. 3 
 
A
 
,
 
 Epidermis
 
), macrophage
but not T cell line tropic virus was recovered from emigrant
cells. Not all cocultures showed transmission of macrophage
tropic virus to T cells, indicating that only a small propor-
tion of the cells migrating from the skin explants carried in-
fectious virus. Activated as well as resting T cells were used
to maximize the amplification of virus carried by the emi-
grant cells. As expected from previous work with blood
DCs (20, 25) coculture with mitogen-activated cells rather
than allogeneic cells resulted in more frequent recovery of
virus during coculture (Fig. 3 
 
B
 
, see also Fig. 5). Under
conditions optimal for recovery of emigrant cells from the
epidermis, where the dermis was removed after epidermal
virus exposure and the emigrant cells from the epidermis
examined for virus carriage, T cell line tropic virus was not
transferred by the emigrant cells (Fig. 3 
 
B
 
).
These observations implicated cells in the epidermis as
the selectors for macrophage tropic virus. To test this fur-
ther, HIV-1 was added to the epidermal surface (epidermis)
or to the entire abraded skin explants (medium), and after
culture, the dermal and epidermal layers were separated by
dispase treatment. The effect of dispase digestion at 4
 
8
 
C on
free virus and activated PBMCs was tested. Viral p24 was
reduced and reverse transcriptase undetectable in dispase-
treated virus and dispase treatment markedly reduced the
infectivity of virus stocks and the expression of the leu3a
epitope of CD4 that is expressed on T cells and is involved
in viral entry (Fig. 4). The dispase treatment during separa-
tion of dermis and epidermis is, therefore, likely to mark-
edly reduce any subsequent infection of the migrating cells
through an effect on the target cells and probably also on
virus infectivity. After epidermal virus exposure, HIV-1 was
not recovered from the dermal sheets if the separation was
performed within 18 h, indicating some delay in the move-
ment into the dermis of cells carrying virus from the site of
HIV-1 exposure in the superficial epidermis. In abraded skin,
explants exposed to virus by adding virus to the culture
medium (Fig. 5, 
 
Medium
 
) before dispase treatment, both
Figure 2. After epidermal ex-
posure, macrophage tropic, but
not T cell line tropic, HIV-1 is
carried by the emigrant cells
from the skin explants. (A) Skin
explants were prepared from skin
after abrading the epidermal sur-
face (see Materials and Methods).
10,000 TCID50 of virus was
added to a contained area of the
epidermal surface (Epidermis) of
skin in 100 ml of medium and
incubated overnight at 378C.
The T cell tropic viral isolate
HIV-1228 (lanes 1–3) and mac-
rophage tropic isolates HIV-1Ba-L
(lanes 4–6) and HIV-1676 (lanes
7–9) are shown. The epidermal
surface was washed free of virus
and floated on 5 ml of medium
for 3 d at 378C. The emigrant
cells were washed and cocul-
tured in 24-well plates with 106
unstimulated peripheral blood
lymphocytes. At day 8, coculture
cells were lysed and analyzed by
semiquantitative PCR at three
dilutions (lanes 1, 4, and 7: neat
lysate; lanes 2, 5, and 8: 1/10 ly-
sate; lanes 3, 6, and 9: 1/100 ly-
sate). PCR controls were the la-
tently infected cell line 8E5
diluted in uninfected 105 PBLs;
4, 104; 3, 103; 2, 102; 1, 101; 0,
100; and -ve, 0 8E5 cells/reac-
tion. HIV-1 p24 antigen con-
centrations in culture superna-
tants collected on day 8 were
measured by enzyme-linked im-
munoabsorbant assay (HIV EIA; Abbott, Abbott Park, IL). (B) Viral replication in cocultures was detected by RTase activity in culture supernatants
taken on days 0, 2, 4, 6, and 8. Results shown are representative of four separate experiments.1627 Reece et al.
the epidermal and dermal emigrants carried macrophage
tropic HIV-1.
The differences in the ability of emigrant cells from der-
mis and epidermis to carry T cell line tropic virus may be
due to differences in phenotype of the DCs in the dermis
and epidermis (17), to the different composition of the em-
igrant cells from the two skin layers, or to exposure of DCs
to HIV-1 at different stages of cellular maturation. We
found emigrants from dermis and epidermis differed in the
proportion of T cells and DC–T cell conjugates (Figs. 1,
and 6 A). In a series of seven experiments in which the em-
igrant cells were sorted, analysis of the low density dermal
emigrant cells showed a mean (6SD) of 13.2 (11.2)% CD31
T cells, 9.7 (15.2)% DC–T cell conjugates, and 9.9 (7.0)%
DCs compared with 3.2 (3.6)%, 1.5 (2.3)%, and 5.2 (4.4)%,
respectively, for epidermis. A higher proportion of DCs in
the epidermis were found as single unconjugated DCs
(70% compared with 50% for dermal DCs), but by flow cy-
tometric analysis there was no significant difference in the
distribution of these populations in skin after exposure to T
cell or macrophage tropic virus. To confirm that DCs rather
than other cell populations were responsible for virus selec-
tion and carriage, DCs from the dermis and epidermis were
sorted by flow cytometry and added to allogeneic PBMCs
in limiting dilution. The T cell line tropic virus isolate
HIV-1NL4.3 (Fig. 6 B) was recovered during coculture from
dermal, but not from epidermal, DCs. In contrast, mac-
rophage tropic virus HIV-1Ba-L (Fig. 6 B) was recovered
Figure 4. Effects of dispase
on HIV and target cells. (A)
CD4 T cells from peripheral
blood were cultured for 2 h at
48C in dispase concentrations
between 0.1 and 10 mg/ml.
Cells were washed and labeled
with CD4 (OKT4) and leu3a.
The leu3a, but not OKT4
(CD4), epitope of the CD4 re-
ceptor recognized by HIV-1 was
removed at concentrations of 1
mg/ml or greater. (B) Virus pro-
duction from SEB (40 ng/ml)-
stimulated PBLs was reduced
when dispase-treated virus was
used to infect the cells. Dispase
treatment for 2 h at 48C at con-
centrations of dispase .0.1 mg/
ml removed RTase activity (RT
cpm/ml) and p24 (ng/ml) activ-
ity from the HIV-1Ba-L virus
stocks.
Figure 3. Epidermal, but not dermal, exposure to HIV-1 results in se-
lective carriage of macrophage tropic virus by emigrant cells. (A) Culture
conditions were as described in Fig. 2. HIV-1228 or HIV-1Ba-L (10,000
TCID50) was added directly to the underlying culture medium (Medium)
and to the surface (Epidermis) of abraded skin explants (3–4 cm2). After 16 h,
the virus was removed and the skin placed back in culture for 4 d. Migrat-
ing cells were treated with collagenase, washed, and added to 106 unstim-
ulated PBLs. On day 10, coculture cells were lysed and analyzed for gag
sequences by semiquantitative PCR. Results are for nine replicate skin
explants exposed to 228 and 10 exposed to Ba-L via epidermis, and for
duplicate cultures exposed via the culture medium. (B) Similar culture
conditions to A. Abraded skin explants were exposed to 10,000 TCID50
of HIV-1Ba-L or HIV-1228 by adding virus to the culture medium (Me-
dium). After 16 h, the explants were washed and half were left as explants
and half were treated with dispase to separate epidermal and dermal layers.
Skin explants (Split skin) and epidermal sheets (Epid. Sheet) were placed back
in culture. Emigrating cells were harvested on day 4 and cocultured with
106/well unstimulated or SEB (40 ng/ml) -stimulated PBLs. PCR for HLA-
DQ and gag sequences were performed on lysates of cocultures on day 10.1628 HIV-1 Selection by Epidermal Dendritic Cells
from both the sorted epidermal and dermal DCs at a fre-
quency higher than from the dermal DC–T cell conjugates.
In keeping with the results obtained using bulk emigrant
cell populations, only a small proportion of sorted DCs car-
ried virus. After exposure to macrophage tropic virus
,0.5% of the DCs sorted from the cells emigrating from
the epidermis could transmit infection to T cells (Fig. 6 B).
Figure 5. Emigrant cells from epidermal, but not dermal, sheets selec-
tively carry macrophage tropic virus. Abraded skin explants were exposed
to 10,000 TCID50 of HIV-1Ba-L by adding virus to the culture medium.
After overnight incubation, the virus was removed, half the treated skin
explants were left intact, and the remainder were treated with dispase to
enable the epidermis to be separated from the dermis. (A) The skin ex-
plants (Split skin), and epidermal and dermal sheets were cultured by float-
ing on medium in 6-well plates. After 4 d, migrating cells from the indi-
vidual wells were harvested and added to unstimulated (PBL) and stimulated
PBLs (106 SEB activated blasts/well) in IL-2 supplemented medium. Cells
were lysed on day 14 and analyzed for HIV-1 gag sequences by PCR. (B)
Virus production in cocultures of stimulated PBLs and emigrant cells
from epidermis and dermis. HIV-1Ba-L was added only to epidermal sur-
face (top) and dispase treated after the overnight virus pulse. Virus produc-
tion was measured by RTase in culture supernatants from intact skin ex-
plants (Split skin), epidermal sheets (Epid. sheet), and the dermal sheets
(Dermal sheet) and plotted against time in culture.
Figure 6. Dendritic cells in the epidermis select for macrophage tropic
virus. Abraded skin explants were pulsed with 1,000 TCID50/ml (z5,000
TCID50) of HIV-1Ba-L by adding virus to the medium overnight at 378C.
After dispase treatment, epidermal and dermal sheets were floated in me-
dium for 3 d. Migrating cells were treated with collagenase and separated
over a step metrizamide gradient, stained with FITC–HLA-DR and PE-
CD3, and sorted for DCs using a cell sorter. (A) As previously shown
(17–19), cells migrating from the dermis contained DCs, T cells, and
DC–T cell conjugates, whereas cells from the epidermis contained DCs
and DC–T cell conjugates, but few CD31 cells. (B) Sorted cells were an-
alyzed for their ability to transmit infection by diluting into coculture
with T cells. Half log10 dilutions of the sorted emigrant cells (104) were
performed in 96-well plates with SEB-stimulated PBLs (105/well) in me-
dium containing 5% IL-2. Virus replication in cocultures was assessed by
lysing cocultures on day 10 and analyzing for gag sequences using PCR.
At the highest cell concentration, the PCR reactions contained the equiv-
alent of 2,500 sorted cells. Duplicate dilution series for DCs sorted from
epidermal emigrants and DCs, and DC–T cell conjugates from dermal
emigrants from Ba-L exposed skin are shown. Dilution series for DCs
sorted from epidermis and dermis of NL43 exposed skin are shown in the
lower two panels.1629 Reece et al.
Infection of cultured blood DCs in vitro has up to now
not shown selective infection of DCs by virus with a spe-
cific biological phenotype (25, 42, 43). Monocyte-derived
DCs (23, 44), DCs cultured from precursors (43), or emi-
grant DCs from skin (21–24) show little (45) or no selec-
tivity of viral entry. Both emigrant DCs from skin and
monocyte-derived DCs express CXCR4 and CCR5 re-
ceptors (23, 43). In contrast, we have now shown selective
transmission of macrophage tropic virus by the emigrants
from the epidermis.
A differential effect of HIV-1 on DC migration such that
T cell tropic virus, but not macrophage tropic HIV-1–inhib-
ited DC migration, could result in such preferential carriage
of macrophage tropic virus. We did not observe this in the
dermis where dermal DCs, including sorted DCs, could
carry both viral phenotypes. If this mechanism operates, it
must be specific for Langerhans cells.
DC maturation could account for differences between
our observations and the previously reported nonselective
HIV-1 transmission by DCs and the transmission of all iso-
lates by dermal DCs. The resident immature epidermal
DCs are likely to be the cells initially exposed to virus dur-
ing epidermal exposure. The DCs themselves carried HIV-1
since the DCs sorted to exclude T cells and DC–T cell
conjugates were at least as effective as the highly susceptible
DC–T cell conjugates in transmitting virus to allogeneic T
cells. All strains of HIV-1 probably bind to the mature and
immature DCs (40), and differences in carriage by epider-
mal DCs in situ compared with the cultured DCs and der-
mal DCs may reflect more efficient antigen uptake and
processing pathways in the immature DCs (46, 47). Virus
carriage without infection may be important in DC–T cell
transmission from mature DCs (43, 48), but whether this
mechanism of carriage is present in immature DCs is un-
clear. We hypothesize that virus that binds to immature
DCs but lacks the ability to bind or enter by CCR5 may
reach the degradative pathways and be destroyed before
cognate interactions and infection of T cells can occur. In-
troduction of virus into the dermis where more mature
emigrating DCs expressing the alternative coreceptors are
present may allow infection of activated dermal DCs or
DC–T cell conjugates. This will partially abrogate the re-
quirement for CCR5 usage and allow infection with a
wide range of viral phenotypes. It may also contribute to
the infrequent infection of subjects homozygous for the
CCR5 deletion (49). During transmission and viral entry, a
requirement for HIV-1 to infect resident DCs, rather than
a requirement to infect macrophages, may be critical in the
selection of the macrophage tropic virus that can efficiently
use the CCR5 coreceptor.
Discussion
Although HIV-1 macrophage tropism has been de-
scribed in terms of the ability to infect macrophages, it is
not clear that this is due to viral targeting of monocytes or
macrophages in vivo. Macrophage tropism of HIV-1 iso-
lates is measured using monocyte-derived macrophages,
usually after 5–7 d of culture. Different HIV-1 isolates vary
widely in their ability to use CCR5 and enter peripheral
blood–derived macrophages (26, 27) or tissue macrophages,
but entry into freshly isolated monocytes is blocked before
reverse transcription (28) and viral load in macrophages
from lymphoid tissue is low (29). A requirement for infec-
tion of macrophages for the entry and subsequent expan-
sion of HIV-1 has nevertheless been inferred from the ob-
servation of initial infection with macrophage tropic virus
(11). Infection of macrophages in uterine cervical tissue ex-
plants by macrophage tropic, but not by nonmacrophage
tropic, HIV-1 isolates has been found (30). Recent data on
coreceptor usage by macrophage tropic virus, however,
suggests macrophages may not be strong selectors for
CCR5 usage, as they allow entry by a range of coreceptors
(31). Although primary infection with virus of SI pheno-
type has been reported (32–34) subjects homozygous for a
deletion within CCR5, but with intact CCR2b, CCR3,
and CXCR4 genes have nearly complete protection from
all HIV-1 infection (35, 36) arguing both for dual tropism
of any SI isolates found in primary infection and for infec-
tion of cells that select for viral usage of CCR5 as an early
event in the establishment of HIV-1. DCs have been con-
sidered important in carriage of virus from skin to the
lymph node during transmission of HIV-1 and have been
implicated as the cells carrying virus from the skin or mu-
cosa to lymph nodes in primate models (37, 38), but their
role in selecting for macrophage tropism or CCR5 core-
ceptor usage has so far been unclear.
Cultured blood and skin DCs efficiently activate T cells
and induce productive infection (22, 25, 39), even when
only low levels of infection are present in the DCs (21).
The emigrant cells from skin explants may also allow virus
production in migrating DC–T cell conjugates in the ab-
sence of cognate interactions or T cell activation (22, 40).
The formation of such DC–T cell conjugates during mi-
gration from skin may allow efficient transfer of virus from
Langerhans cells and be critical in the initial transfer of virus
to responding T cells. The observation of DC-derived syn-
cytia in the T cell–rich areas near the crypts of the oropha-
ryngeal lymphoid tissue (41) also implies that the formation
of DC–T cell conjugates represents sites of virus produc-
tion in vivo. DCs clearly can provide an efficient pathway
for introducing infection to T cells. Any virus selection by
DCs during this process would result in predominance of
“DC tropic” viral phenotypes during the subsequent viremia.
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